ECM Weekly (16th July 2023) - LG Energy, Socionext, Plus Alpha, Syngenta, Cinema XXI, Genda, Fadu
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
384 Views
ECM Weekly (2nd July 2023) - Tryt, J&T Express, Redox, Kelun, 4Paradigm, SIA, M&A Research, Walsin
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
382 Views
ECM Weekly (11th June 2023) - Alibaba, Tencent, PDD, Redox, Amman, Kotak, Infratil, Skymark
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
390 Views
China Healthcare Weekly (Apr.28) - Four Stages of China Biotech, The Real Foothold of R&D, Kelun
The real foothold of pharmaceutical company is “Development” rather than “Research”. China biotech will go through four stages: 2015-2019, 2019...
382 Views
Pre-IPO Kelun Biotech - Debut Is the Peak, and Then It Wanes?
After out-licensing all valuable core assets to Merck, Kelun-Biotech's remaining pipeline has limited value. As core R&D team have left, the lack...
330 Views